Nevro announces Carelon publication on new interventional pain management policy

Nevro announced that Carelon Healthcare, a healthcare services company, will be publishing a new interventional pain management policy that expands spinal cord stimulation, or SCS, coverage for painful diabetic neuropathy, or PDN. The policy, which will go into effect on April 14, represents an increase in PDN patient coverage by nearly 43M additional lives. Payers that utilize Carelon Healthcare include Anthem Blue Cross in California; Anthem Blue Cross Blue Shield in Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri, New Hampshire, Nevada, New York, Ohio, Virginia, and Wisconsin; AmeriHealth; Empire BCBS; Independence Blue Cross; and various Managed Medicaid plans.